Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement.
BioGeometry is a digital biology pioneer company that specializes in AI-driven protein design and R&D platform.
Sanyou Bio is a world-leading high-tech biotechnology enterprise focusing on R&D and services of innovative biologic drugs.
Both parties will leverage their...
AUSTIN, Texas, July 10, 2024 -- Oracle has introduced advanced features in its AI-powered Oracle Argus and Safety One Intake solutions to support life science organizations in managing regulatory requirements and increased adverse event case volumes. These new enhancements are designed to boost efficiency, enhance data privacy, and improve...
August Calhoun and Mike Allelunas are poised to advance RLDatix's strategic growth efforts and enhance operational efficiency across North America and globally.
RLDatix, the leading global provider of connected healthcare operations software and services, announces two additions to its executive leadership team. August Calhoun joins as President & General Manager of RLDatix North America, and Mike Allelunas joins as...
Exscientia plc announced it will be expanding its work with Amazon Web Services (AWS) to use the cloud provider’s artificial intelligence (AI) and machine learning (ML) services to power its platform for end-to-end drug discovery and automation.
Exscientia’s platform uses generative AI models and the scalability and flexibility of AWS...
Certara, Inc., a global leader in model-informed drug development, announced it has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software. The transaction is expected to close in the second half of 2024, subject to regulatory approval and other customary closing conditions.
Chemaxon develops leading software...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced that the company’s PurIST algorithmic test has received a proprietary laboratory analysis (PLA) code from the American Medical Association (AMA). The new code will be effective on October 1, 2024. The PurISTSM PLA code is the first...
Iktos, a company specializing in Artificial Intelligence (AI) and Robotics for new drug design, announces the acquisition of Synsight, a French biotech company applying AI and high-content cell imaging to the discovery of novel drug candidates. The operation completes Iktos’ unique platform in AI and Robotics-assisted drug discovery.
Strengthening Iktos’s...
The AI-powered Analytics and Dashboard by Scispot transforms how different departments within a biotech company interact with their data. This new feature enables users to create personalized dashboards for lab R&D, production, and operational data.
Scispot, the leading Gen AI-powered biotech tech stack provider, has introduced AI-powered analytics into its Lab...
Avicenna.AI, a leading medical imaging AI company, has received Medical Device Regulation (MDR) certificate for five of its algorithms from certification body BSI Medical Devices. This development means the company's product portfolio is fully compliant with the European Union's MDR 2017/745, which is now mandatory for medical device companies...
Owkin will bring its world-class data access and AI to the forefront of drug discovery and development, analysing multimodal patient data in a privacy-enhanced way
Owkin , the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany,...
